Hepatocellular carcinoma treated with sorafenib: early detection of treatment response and major adverse events by contrast‐enhanced <scp>US</scp>

Katsutoshi Sugimoto, Fuminori Moriyasu, Kazuhiro Saito, N. Rognin, Naohisa Kamiyama, Yoshihiro Furuichi, Yasuharu Imai

Liver International · 2013 · 58 citations · 25 references

Abstract

DCE-US may be useful for the early prediction of tumour response and major AEs in patients with HCC.

References

25